Which hedge funds own ACRV? ACRIVON THERAPEUTICS INC, Q2 2026 13F holders
4 of the hedge funds tracked by WhaleCreep disclosed a position in ACRV (ACRIVON THERAPEUTICS INC) in their Q2 2026 13F filings, worth $24.1m in total. The largest holder by portfolio weight is RA Capital Management at 0.2% of its book. 1 manager opened a new position this quarter: Citadel Advisors.
4tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold ACRV? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.2% | $21.8m | 12,229,396 | 47% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.4m | 758,863 | 0% | held |
| Marshall Wace | Q2 2026 | 0.0% | $946.7k | 531,856 | -5% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $73.5k | 41,276 | – | new |
How has hedge fund ownership of ACRV changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $24.1m |
| Q1 2026 | 3 | $13.4m |
| Q4 2025 | 3 | $21.7m |
| Q3 2025 | 2 | $16.2m |
| Q2 2025 | 2 | $10.5m |
| Q1 2025 | 2 | $17.0m |
| Q4 2024 | 2 | $50.5m |
| Q3 2024 | 2 | $58.7m |
| Q2 2024 | 2 | $48.7m |
| Q1 2024 | 2 | $35.1m |
| Q4 2023 | 1 | $23.7m |
| Q3 2023 | 1 | $46.0m |
| Q2 2023 | 1 | $62.3m |
| Q1 2023 | 1 | $61.0m |
| Q4 2022 | 1 | $55.4m |
Counts every tracked manager that disclosed ACRV in that quarter's filing, including managers that have since stopped filing.